Comparison of Lithium, Aripiprazole and Olanzapine as Augmentation to Paroxetine for Inpatients With Major Depressive Disorder

Therapeutic Advances in Psychopharmacology
doi 10.1177/2045125313514767
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2012English

Efficacy and Tolerability of Mirtazapine Versus Paroxetine in the Treatment of Major Depressive Disorder

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2012English

Efficacy of Adjunctive Aripiprazole in Patients With Major Depressive Disorder Whose Symptoms Worsened With Antidepressant Monotherapy

CNS Spectrums
PsychiatryMental HealthNeurology
2014English

Comparison of Serum Protein Profiles Between Major Depressive Disorder and Bipolar Disorder

BMC Psychiatry
PsychiatryMental Health
2020English

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

Dental Patients With Major Depressive Disorder

Current Oral Health Reports
2014English

Depression Impairs Learning, Whereas the Selective Serotonin Reuptake Inhibitor, Paroxetine, Impairs Generalization in Patients With Major Depressive Disorder

Journal of Affective Disorders
PsychiatryClinical PsychologyMental Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy